Latest Regulatory Approval News

Page 16 of 346
Minerals Exploration has expanded its New Zealand exploration pipeline after broad gold intersections at Jubilee South and high-grade tungsten results at Invincible. The next phase is more ambitious, but A$1.96 million in cash covers only 1.91 quarters at the latest spending rate.
Maxwell Dee
Maxwell Dee
16 Oct 2026
Vysarn delivered another year of rapid earnings growth, with revenue rising 31% and net profit after tax climbing 41% to $15.11 million. The bigger test now is whether its $65.3 million capital raise and Welltech acquisition can turn a growing collection of water businesses into a genuinely national platform.
Victor Sage
Victor Sage
16 Oct 2026
Firebrick Pharma has secured Philippine marketing approval for Nasodine Nasal Spray as an over-the-counter antiseptic, opening a potential launch in the 116 million-person market from early 2027. The approval remains subject to post-approval documentation and future revalidation.
Victor Sage
Victor Sage
16 Oct 2026
Alcoa delivered a $483 million third-quarter profit and its sixth consecutive quarter of higher aluminium production, while South32 shareholders approved the company’s planned upstream asset acquisition. The deal remains targeted for completion in the first half of 2027, with $2.6 billion of acquisition financing now raised.
Victor Sage
Victor Sage
16 Oct 2026
Santana Minerals has moved the Bendigo-Ophir Gold Project closer to development, with a draft Fast-track Approvals decision expected in the December quarter and a competitive project debt process now underway. Strong Rise and Shine drilling and an A$179.7 million quarter-end cash balance provide further support, although construction remains conditional on approvals, financing and a final investment decision.
Maxwell Dee
Maxwell Dee
16 Oct 2026
Bass Oil’s September revenue surged to A$1.69 million as Bunian 6 drove a sharp increase in Indonesian production and Cooper Basin sales resumed. The company is now targeting first gas from Vanessa by year end, subject to regulatory approval and remaining site work.
Victor Sage
Victor Sage
15 Oct 2026
Medical Developments International CEO Brent MacGregor is stepping down after six years, with CFO Anita James taking over as interim CEO from 15 October. The board has begun searching for a permanent successor as MacGregor prepares to return to North America.
Ada Torres
Ada Torres
15 Oct 2026
BLS Pharmaceuticals has opened FY27 with record quarterly revenue, positive operating cash flow and reaffirmed full-year guidance. The report contains conflicting Q1 revenue figures of $26.7 million and $27.5 million, while its Scotland expansion remains subject to regulatory approval.
Victor Sage
Victor Sage
15 Oct 2026
The Supreme Court of Western Australia has approved Central Asia Metals’ scheme to acquire 100% of Cygnus Metals, moving the transaction into its final procedural phase. Cygnus expects the scheme to become effective on 15 October, with implementation scheduled for 27 October.
Maxwell Dee
Maxwell Dee
14 Oct 2026
Energy Fuels has amended its proposed acquisition of VAC after a customer dispute escalated into arbitration and lender forbearance at VAC’s US magnet plant. The filing also reveals VAC’s six-month net loss of €57.4 million, substantial debt and reliance on shareholder support ahead of the proposed transaction.
Victor Sage
Victor Sage
14 Oct 2026
Central Asia Metals has secured the Kazakhstan regulatory approval required for its proposed acquisition of Cygnus Metals, removing a key condition before tomorrow’s Second Court Hearing. The scheme remains subject to the court process and any remaining conditions, with implementation still targeted for 27 October.
Maxwell Dee
Maxwell Dee
13 Oct 2026
Anatara Lifesciences will manufacture an approximately 10,000-capsule demonstration batch of its AOC anti-obesity compound after deciding further pre-clinical work and an immediate clinical trial are not required. The company ended September with $551,000 in cash, helped by a $318,402 R&D tax rebate.
Ada Torres
Ada Torres
13 Oct 2026

Browse the archive

Full archive